OSR Health, Inc.(OSRH)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,563 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
OSRH Stock Analysis & AI Quality Score
AI stock analysis and institutional research for OSR Health, Inc. (OSRH), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores OSRH at 25.0/100 on a 32-signal composite quality model, placing it at rank #2,563 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue growth (3.1) and balance sheet strength (14.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), OSR Health, Inc. reports quarterly revenue of $484.1K, net income of $-3.5M, free cash flow of $-1.0M. Top institutional holders of OSRH by reported 13-F value include GEODE CAPITAL MANAGEMENT,, XTX Topco Ltd, TORONTO DOMINION BANK, based on the most recent SEC filings. OSRH trades on the Nasdaq exchange and files with the SEC under CIK 1840425. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OSRH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for OSR Health, Inc. directly from SEC EDGAR. OSR Health, Inc.'s 13F Pro composite quality score has ranged between 25 and 27 since 2026, currently 25.0 — a stable long-term trajectory across 8 quarterly and live scoring snapshots.
Revenue
Q1 2026
$484.1K
Net Income
Q1 2026
$-3.5M
Free Cash Flow
Q1 2026
$-1.0M
D/E Ratio
Q1 2026
0.02
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
Net Income
Operating Income
-51714.2% YoYEPS (Diluted)
-72627.3% YoYTotal Assets
+13868.9% YoYTotal Debt
+104.0% YoYOp. Cash Flow
-102096.8% YoY| Metric | FY 2025 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Revenue | $2.9M | — | — | — |
| Net Income | — | $-126.00 +96.2% | $-3.3K | — |
| Operating Income | $-18.3M -51714.2% | $-35.4K -969.8% | $-3.3K | — |
| EPS (Diluted) | $-0.80 -72627.3% | $-0.00 | — | — |
| Total Assets | $171.2M +13868.9% | $1.2M +73.9% | $705.1K | — |
| Total Debt | $2.3M +104.0% | $1.1M | — | — |
| Operating Cash Flow | $-4.3M -102096.8% | $-4.2K -818.7% | $-461.00 | — |
AI Insight: OSRH Ratio Trends
Insufficient data to assess OSRH's financial trends — only ROA figures available, all negative through Q4 2024.
• ROA deteriorated from -1.9% in Q2 2024 to -4.6% in Q4 2024, signaling worsening asset efficiency.
⚠ No margin, profitability, or leverage metrics reported for any period; unable to assess operational or financial health.
Get alerted when OSRH's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for OSR Health, Inc. including:
Top Institutional Holders of OSRH
GEODE CAPITAL MANAGEMENT, LLC
$63.8K105,743 shXTX Topco Ltd
$36.6K60,746 shTORONTO DOMINION BANK
$24.1K40,000 shVANGUARD CAPITAL MANAGEMENT LLC
$22.5K37,373 shVANGUARD FIDUCIARY TRUST CO
$10.3K17,029 shStoneX Group Inc.
$9.3K15,435 shUBS Group AG
$2.7K4,476 shTower Research Capital LLC (TRC)
$2.5K4,141 shCITIGROUP INC
$232.00384 shSBI Securities Co., Ltd.
$46.0077 sh
| Fund | Value | Shares |
|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $63.8K | 105,743 |
| XTX Topco Ltd | $36.6K | 60,746 |
| TORONTO DOMINION BANK | $24.1K | 40,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | $22.5K | 37,373 |
| VANGUARD FIDUCIARY TRUST CO | $10.3K | 17,029 |
| StoneX Group Inc. | $9.3K | 15,435 |
| UBS Group AG | $2.7K | 4,476 |
| Tower Research Capital LLC (TRC) | $2.5K | 4,141 |
| CITIGROUP INC | $232.00 | 384 |
| SBI Securities Co., Ltd. | $46.00 | 77 |
More Healthcare Companies
View all Healthcare →Put OSRH on your watchlist
Track score changes the day OSR Health, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is OSRH a good stock to buy?
13F Pro's AI-powered analysis of OSR Health, Inc. (OSRH) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for OSRH are available on the OSRH stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own OSRH?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling OSRH. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of OSR Health, Inc.'s investment landscape.